Biomedical Engineering Reference
In-Depth Information
142. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A,
et al. Differential expression of chemokine receptors and chemotactic respon-
siveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998; 187:
129-134.
143. Sallusto F, Kremmer E, Palermo B, Hoy A, Ponath P, Qin S, et al. Switch in
chemokine receptor expression upon TCR stimulation reveals novel homing
potential for recently activated T cells. Eur J Immunol 1999; 29:2037-2045.
144. Lukacs NW. Migration of helper T-lymphocyte subsets into inflamed tissues.
J Allergy Clin Immunol 2000; 106:S264-S269.
145. Luster AD. Mechanisms of disease: chemokines-chemotactic cytokines that
mediate inflammation. N Engl J Med 1998; 338:436-445.
146. Lukacs NW, Oliveira SH, Hogaboam CM. Chemokines and asthma: redun-
dancy of function or a coordinated effort? J Clin Invest 1999; 104:995-999.
147. SaettaM, Mariani M, Panina-Bordignon P, Turato G, Buonsanti C, Baraldo S,
et al. Increased expression of the chemokine receptor CXCR3 and its ligand
CXCL10 in peripheral airways of smokers with chronic obstructive pul-
monary disease. Am J Respir Crit Care Med 2002; 165:1404-1409.
148. Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, et al.
Chemokine receptor specific for IP10 and mig: structure, function, and expres-
sion in activated T-lymphocytes. J Exp Med 1996; 184:963-969.
149. Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, et al.
The chemokine receptors CXCR3 and CCR5 mark subsets of T cells asso-
ciated with certain inflammatory reactions. J Clin Invest 1998; 101:746-754.
150. Carbone FR, Kurts C, Bennett SR, Miller JF, Heath WR. Cross-presentation:
a general mechanism for CTL immunity and tolerance. Immunol Today 1998;
19:368-373.
151. Bevan MJ. Cross-priming for a secondary cytotoxic response to minor H anti-
gens with H-2 congenic cells which do not cross-react in the cytotoxic assay.
J Exp Med l976; 143:1283-1288.
152. Gordon RD, Mathieson BJ, Samelson LE, Boyse EA, Simpson E. The effect
of allogeneic presensitization on H-Y graft survival and in vitro cell-mediated
responses to H-y antigen. J Exp Med 1976; 144:810-820.
153. Carbone FR, Bevan MJ. Class I-restricted processing and presentation of exo-
genous cell-associated antigen in vivo. J Exp Med 1990; 171:377-387.
154. Bachmann MF, Kundig TM, Freer G, Li Y, Kang CY, Bishop DH, et al.
Induction of protective cytotoxic T cells with viral proteins. Eur J Immunol
1994; 24:2228-2236.
155. Kovacsovics-Bankowski M, Clark K, Benacerraf B, Rock KL. Efficient major
histocompatibility complex class I presentation of exogenous antigen upon
phagocytosis by macrophages. Proc Natl Acad Sci USA 1993; 90:4942-4946.
156. Harding CV, Song R. Phagocytic processing of exogenous particulate antigens
by macrophages for presentation by class I MHC molecules. J Immunol 1994;
153:4925-4933.
157. Srivastava P. Interaction of heat shock proteins with peptides and antigen
presenting cells: chaperoning of the innate and adaptive immune responses.
Annu Rev Immunol 2002; 20:395-425.
